quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:39:54·2001d
PRRelease
Mylan N.V. logo
Pfizer Inc. logo

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

MYL· Mylan N.V.PFE· Pfizer Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • MYL
    Mylan N.V.
    Health Care
  • PFE
    Pfizer Inc.
    Health Care

Recent analyst ratings

  • Mar 2PFEUpdateArgus$35.00
  • Feb 25PFEUpdateRBC Capital Mkts$25.00
  • Feb 20PFEUpdateBarclays$25.00
  • Feb 12PFEUpdateDaiwa Securities$27.00
  • Jan 7PFEUpdateUBS$25.00
  • Dec 2PFEUpdateCitigroup$26.00

Related

  • PR2h
    Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
  • PR1d
    Pfizer Declares Second-Quarter 2026 Dividend
  • PR2d
    Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
  • PR4d
    U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
  • INSIDER6d
    SEC Form 4 filed by Bourla Albert
  • INSIDER7d
    SEC Form 4 filed by Bourla Albert
  • INSIDER13d
    SEC Form 3 filed by new insider Hancock Dennis P
  • PR14d
    Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022